Skip to main content

TEVA 8229 TEVA 8229 Pill - yellow capsule-shape, 16mm

Pill with imprint TEVA 8229 TEVA 8229 is Yellow, Capsule-shape and has been identified as Sunitinib Malate 37.5 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Sunitinib is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 8229 TEVA 8229

Sunitinib malate 37.5 mg TEVA 8229 TEVA 8229

Sunitinib Malate

TEVA 8229 TEVA 8229
37.5 mg
16.00 mm
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
Inactive Ingredients
croscarmellose sodium, magnesium stearate, mannitol, povidone k30, gelatin, titanium dioxide, ferric oxide yellow, ferrosoferric oxide, D&C Yellow No. 10 Aluminium Lake, FD&C Blue No. 1 Aluminium Lake, FD&C Blue No. 2 Aluminium Lake, FD&C Red No. 40, shellac, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.